257. Hepatic glycogenosis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 17 / Drugs : 32 - (DrugBank : 8) / Drug target genes : 2 - Drug target pathways : 7
| Other names | Liver glycogenosis;Hepatic glycogen storage disease;Liver glycogen storage disease; | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
120 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 257-01, 257-02 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | - | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 257-1. | Glycogen storage disease type I;GSDI;von Gierke disease;Glucose-6-phosphatase deficiency;G6Pase deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Cori syndrome;Forbes disease;Forbes syndrome;Glycogen debranching enzyme deficiency;Glycogen storage disease type VI;GSDVI;Hers disease;Hers syndrome;Hepatic phosphorylase deficiency;Liver phosphorylase deficiency;Glycogen storage disease type IX;GSDIX;Phosphorylase kinase deficiency; | 8-5-66. Glycogen storage disease type I 8-5-67. Glycogen storage disease type III 8-5-70. Glycogen storage disease type VI 8-5-72. Glycogen storage disease type IX | |
| 257-2. | Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Adult polyglucosan body disease; | 8-5-68. Glycogen storage disease type IV | |